(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

ANEST

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: MistaEscritório: US

Snapshot rápido

ANEST

ST13

US500000079355844

Classe

5, 10, 42, 44

Pedido

79355844

Registro

7273115

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

35

Atualização mais recente

15/11/2025

Classificação

Registrada

Tipo de marca

Mista

Classes Nice

5, 10, 42, 44

Data de depósito

07/04/2022

Data de registro

16/01/2024

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

16/01/2024

Última transação

15/11/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

5

Tipo de titular

25

Localização do titular

DE

Examinador

KHAN,ASMAT A

Unidade examinadora

M50

Localização atual

PUBLICATION AND ISSUE SECTION

Descrição da marca

The mark consists of the stylized word ANEST.

Titulares e representantes

Titulares

Helm AG
Welding GmbH & Co. KG
5MED GmbH

Representantes

Katrin Lewertoff Lewertoff IP Law Group, LLC

Classificação técnica

Classes Nice

Classe 5Classe 10Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Pharmaceutical preparations for use in anesthesiology and intensive care medicineanalgesicsantibiotics and anesthetics for surgical and non-surgical use; Medicinal healthcare preparations to reduce strong pain after surgeries and in emergenciesto prevent bacterial infectionsfor use in anesthesiology and intensive care medicine; Medicinal preparations and substances to reduce strong pain after surgeries and in emergenciesto prevent bacterial infectionsfor use in anesthesiology and intensive care medicine; Medicine to reduce strong pain after surgeries and in emergenciesto prevent bacterial infectionsfor use in anesthesiology and intensive care medicine; Medicines for human purposes to reduce strong pain after surgeries and in emergenciesto prevent bacterial infectionsfor use in anesthesiology and intensive care medicine

Classe 10

Medical apparatus and instruments for use in anesthesiology and intensive care medicine; Veterinary apparatus and instruments for use in anesthesiology and intensive care medicine; Dental apparatus and instruments for use in anesthesiology and intensive care medicine; Medical devicesdevices for transporting medications into the patientapplicators in the nature of disposable syringes for medical useanesthetic inhalers sold emptyimplantable portsdrug delivery patches sold without medicine for use in anesthesiology and intensive care medicine; Medical instruments for use in anesthesiology and intensive care medicine

Classe 42

Research and development of new products for others; Technical writing for others; Technical project studiestechnical research in the field of pharmaceutical studies; Medical research services; Conversion of physical data and documents into electronic media format; Technical research in the field of pharmaceutical studies; Hosting of databaseshosting of on-line databases of others; Providing search engines for the internet; Quality control for others; Chemical analysis; Clinical trialsscientific research in the nature of conducting clinical trials for others

Classe 44

Medical clinic services; Provision of pharmaceutical informationproviding information relating to diagnosticprophylactic and therapeutic properties of pharmaceuticals; Hospitalshospital services; Pharmacy advicepharmaceutical advice; Pharmaceutical consultation; Medical consultation; Medical assistance; Medical services; Advice in relation to medical services and health care provided at medical clinics for business and health staff; Health care

Publicações

Histórico de despachos e eventos da marca no USPTO.

35 publicações encontradas

NREP

NEW REPRESENTATIVE AT IB RECEIVED

14/11/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/06/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/06/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/06/2024

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

22/05/2024

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

11/05/2024

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

17/04/2024

XXCR

GENERIC MADRID TRANSACTION CREATED

17/04/2024

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

16/04/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

16/03/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

16/03/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

16/03/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

16/03/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

16/03/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

16/01/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

16/01/2024

GPNX

NOTIFICATION PROCESSED BY IB

31/10/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

31/10/2023

PUBO

PUBLISHED FOR OPPOSITION

31/10/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

11/10/2023

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

11/10/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/10/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

23/09/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

22/09/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

22/09/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

22/09/2023

RFNP

REFUSAL PROCESSED BY IB

20/04/2023

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

28/03/2023

RFRR

REFUSAL PROCESSED BY MPU

27/03/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

28/01/2023

CNRT

NON-FINAL ACTION WRITTEN

27/01/2023

DOCK

ASSIGNED TO EXAMINER

25/01/2023

MAFR

APPLICATION FILING RECEIPT MAILED

29/11/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

25/11/2022

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

24/11/2022

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace ANEST ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.